Effects of the SGLT2-inhibitor Empagliflozin on Patients With SIADH - the SAND Study
Clinical trial NCT02874807 · COMPLETED
Trial details
- NCT number
- NCT02874807
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-05
- Primary completion
- 2018-12-14
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.